Rob Shick -   CML - Patient of OSHU Knight Cancer Institute

 At age 44, Rob Shick had always been healthy and active, so he was shocked to hear that he had leukemia. He started taking Gleevec, the cancer drug developed by OHSU Knight Cancer Institute Director Dr. Brian Druker. ...
                       
Leukemia survivor Rob Shick
2009, Knight Cancer institute, OHSU (Oregon Health and Science University)

The End of Cancer is within reach
2009, Knight Cancer institute, OHSU (Oregon Health and Science University)

VIDEO


VIDEO


                 More information about  Knight Cancer Institute and leukemia,
                             Oregon Health & Science University (OHSU)
               See  Dr. Brian Druker and Dr. Michael Mauro and Carolyn Blasdel